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Summary Pulmonary rehabilitation is a therapeutic process, which entails taking a
holistic approach to the welfare of the patient with chronic respiratory illness—most
commonly chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation
is considered essential throughout the lifetime management of patients with
symptomatic chronic respiratory disease. It requires the coordinated action of a
multidisciplinary healthcare team in order to deliver an individualised rehabilitation
programme to best effect—incorporating multiple modalities, such as advice onee front matter & 2005
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ess: jreardo@harthosp.smoking cessation, exercise training and patient self-management education, among
others. As core components of pulmonary rehabilitation, exercise training and self-
management education have been shown to be beneficial in improving health-
related quality of life (HRQoL) in patients with chronic respiratory disease. Physical
training can help to reduce the muscle de-conditioning that occurs when the activity
of patients is restricted by their breathlessness and fatigue, and is often associated
with an increase in patient HRQoL. HRQoL can also be improved by the use of self-
management education, which is designed to provide the patient with the skills to
manage the health consequences of their disease. In doing so, patients are better
able to cope with disease symptoms, potentially leading to reduced healthcare
costs.Elsevier Ltd. All rights reserved.
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J. Reardon et al.S20A great deal of research has been conducted to try and fully define which patients
will benefit most from pulmonary rehabilitation. Although progress has been made,
many questions remain as to the best means of delivering rehabilitation, particularly
with respect to the optimum programme of physical training and patient self-
management education.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Pulmonary rehabilitation is a comprehensive, mul-
tidisciplinary intervention designed to reduce
symptoms, and increase functional status and
health-related quality of life (HRQoL) in patients
with chronic respiratory conditions.1–3 Pulmonary
rehabilitation is now seen as integral to the life-
long management of individuals with symptomatic
chronic respiratory illness, rather than being
reserved to manage only those with severe dis-
ease.3 Pulmonary rehabilitation focuses on both the
primary and secondary impairments associated
with respiratory disease. Strategies include exer-
cise training, self-management education, nutri-
tional intervention and psychosocial support.3,4
Reduced physical activity occurs as a result of
chronic breathlessness and fatigue. The subsequent
deconditioning is aggravated by systemic effects
such as peripheral muscle, cardiac, nutritional and
psycho-social dysfunction. Suboptimal self-manage-
ment strategies add to the burden of the disease.
Not surprisingly, peripheral muscle dysfunction is a
major cause of reduced function and participation in
patients with chronic obstructive pulmonary disease
(COPD), hence physical training is crucial in order to
increase exercise capacity, functional status and
associated quality of life (QoL).3
The goal of patient education is to improve
clinical outcomes by teaching self-management
skills, thus increasing self-efficacy and adherence.
Traditionally, education has focused on supplying
the patient with disease-specific information and
appropriate technical skills.5 More recently, how-
ever, patient self-management education—aimed
at teaching patients disease-related problem sol-
ving skills—has been employed.5
For pulmonary rehabilitation programmes to be
successful, they must be continuously tailored to
the individual patient, and administered by a
multidisciplinary team. Consequently, close coordi-
nation is necessary between all team members,
including the patient, the family, the multidisci-
plinary team of health professionals, as well as the
programme co-ordinator and the medical director.
Much research has been conducted to understand
the multi-systemic effects of chronic respiratorydisease, how a comprehensive pulmonary rehabili-
tation programme addresses the resultant func-
tional limitations, which patients will benefit most
from pulmonary rehabilitation, and how best to
administer such programmes. Within this frame-
work, we will discuss recent scientific advances in
our understanding of the core components of
pulmonary rehabilitation—physical training and
patient education—and how they address the
functional limitations seen in chronic respiratory
diseases such as COPD.How do we prescribe physical training in
pulmonary rehabilitation for COPD?
Principles of physical training
Physical training is important, even in healthy
individuals, because muscle deconditioning occurs
naturally as a consequence of inactivity—muscle
mass, and the expression of genes associated with
muscle growth, are both rapidly (within 2 weeks)
reduced with muscle immobilisation.6 However,
these changes are quickly reversed over 6 weeks of
exercise rehabilitation, with changes in gene ex-
pression being detectable as early as 24h after
initiating exercise.6 Because the aetiology of muscle
deconditioning in otherwise healthy individuals is
similar to that in COPD, it is reasonable to assume
that physical training is capable of reversing this
process in these patients.7 Physical training is
essential in order to address the disability (reduc-
tions in functional performance and QoL) that can
arise from muscle deconditioning and peripheral
muscle dysfunction—caused by physical inactivity
(due to chronic breathlessness and fatigue) and the
systemic effects of chronic respiratory disease (Fig.
1).3 Other factors known to play a role in peripheral
muscle dysfunction include poor nutrition and the
effects of certain drugs (e.g. systemic corticoster-
oids8). It is important to note, that there is currently
no direct relationship established between changes
in exercise performance and health status.9 Rather,
improvements in health status with exercise training
likely stem from indirect effects on improved
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Figure 1 The relationship between chronic lung disease,
muscle deconditioning and disability.3
Pulmonary rehabilitation for COPD S21self-efficacy, coping strategies or task-associated
dyspnoea.
The benefits of exercise training in COPD are well
established, and as part of a co-ordinated rehabi-
litation programme, have been shown to improve
exercise tolerance and HRQoL.2 Exercise training
programmes should combine both endurance and
resistance training (multi-gyms, free weights or
isokinetic dynamometry),10,11 and should be of-
fered for at least three sessions per week3—at least
two of which should be supervised. Recent data
have explored the benefits of individualised,12
reduced intensity13 and interval training14 and
provided some indication as to the required
duration of exercise.
Defining the optimum prescription of
physical training
Individualisation
In 1997, Vallet et al.12 published a study illustrating
the importance of individualised training. In this
study, patients with chronic airway limitation were
assigned to 4 weeks of individualised (n ¼ 12) or
standardised (n ¼ 12) stationary bike training. In
the former, training was conducted at the indivi-
dually measured gas exchange threshold (anaerobic
threshold), and in the standardised group was
conducted at 50% of calculated maximal heart rate
reserve. Despite the fact that the target training
level was similar between the two groups, there
were greater physiological improvements (Fig. 2) inFigure 2 The effect of 4 weeks of standard or individua-
lised training on change (7standard error mean) in (A)
minute ventilation (DV 0E), (B) CO2 output (DV
0CO2) and
(C) blood lactate concentration (D[La]), at different
levels of pre-training symptom-limited oxygen uptake, in
patients with COPD.12
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cardiorespiratory responses with reduced ventila-
tion and lactic acidosis), indicating that tailored
training can provide greater benefits than standar-
dised regimens.Intensity
The benefits of training generally increase with
intensity. Gains in exercise tolerance have been
shown to be superior when high intensity targets
are chosen.13 However, there are still benefits to be
gained at lower training intensities. A recent study
authored by Normandin et al.13 compared the
effects of a high-intensity lower extremity endur-
ance programme, with a low-intensity peripheral-
muscle training programme placing emphasis on
the upper extremities (calisthenics), in patients
with COPD (n ¼ 20 for both groups). Both pro-
grammes were conducted during two 30-min ses-
sions, twice-weekly for 8 weeks. After completing
the 8 weeks of training, patients undergoing either
programme showed significant and equivalent im-
provements (Fig. 3) in questionnaire-rated dys-
pnoea (transitional dyspnoea index [TDI]),
functional performance (pulmonary functional sta-
tus scale [PFSS]) and health status (chronic respira-
tory disease questionnaire [CRQ]). Importantly
therefore, in the short term, low-intensity exercise
training provides similar benefits in questionnaire-
based measures as more intensive training meth-
ods, and is more convenient for the patient.Figure 3 Change in chronic respiratory disease ques-
tionnaire (CRQ), pulmonary function status scale (PFSS)
and transition dyspnoea index (TDI) scores from baseline
to 8 weeks among patients undergoing high- or low-
intensity physical training.13Interval training
The use of interval training as opposed to contin-
uous training is one strategy that can be used to
increase exercise load. The benefits of the two
strategies were compared in a study published by
Vogiatzis et al. in 2002.14 In this study, 36 patients
with COPD were assigned to 40min of cycling,
twice-weekly for 12 weeks, either as 30-second
intensive intervals (20 times with a 30-second rest
interval) or continuously at 50% of baseline peak
work rate.14 Both groups showed similar adherence
to the exercise programmes, and had similar
improvements in exercise tolerance and QoL
(CRQ). Importantly, the interval group had less
dyspnoea (Borg scale) during exercise, despite
intermittently exercising at twice the intensity
(Fig. 4).Duration
In 2000, Troosters et al.15 published results from a
study examining the benefits of extended training
programme duration. The effects of an exercise
programme (cycling, walking and strength training)
were compared with usual care over a period of 18
months in patients with COPD (n ¼ 50). At 6
months, those patients undergoing exercise train-
ing had statistically significant improvements in
several outcome measures, including 6-min walking
distance, maximal exercise performance, periph-
eral and respiratory muscle strength and QoL (as
measured by the CRQ). Importantly, most of these
changes were maintained throughout the 18-month
programme.15 Shorter periods of training can also
produce substantial improvements in patient ex-
ercise performance.16 In a randomised trial, GreenFigure 4 Change in chronic respiratory disease ques-
tionnaire (CRQ) scores from baseline to 12 weeks in
patients with COPD undergoing interval or continuous
training.14
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weeks (n ¼ 23) versus 7 weeks of pulmonary
rehabilitation (n ¼ 221). Although there were
trends toward greater improvements in exercise
tolerance in the incremental shuttle walk test and
the treadmill endurance test in the group complet-
ing 7 weeks, the differences between groups did
not reach statistical significance. Notably, the
patients in the 7-week programme had significant
improvements in the major outcome varia-
bles—CRQ total score as well as the domains of
dyspnoea, emotion and mastery—that were great-
er than the patients in the 4-week programme.16 It
is clear, therefore, that even relatively brief (4-
week) periods of training can provide beneficial
effects, and furthermore, that these benefits may
continue to increase after training has ceased.Strategies for enhancing the
effectiveness of pulmonary
rehabilitation in COPD
Advances in our understanding of the pathophysio-
logical basis underlying the airflow limitations,
have allowed us to develop a number of strategies
for improving exercise tolerance in COPD. While
these can be used alone to improve exercise
tolerance in COPD, they can also be adjunctive
therapy to the exercise training of pulmonary
rehabilitation. For example, optimal bronchodila-
tion will allow patients to exercise at a greater
intensity and duration before symptom limitation,
thereby allowing patients to gain greater benefit
from the training.
Supplemental oxygen
In patients with COPD, small increases in the
fraction of inhaled oxygen (FIO2) result in measur-
able improvements in exercise tolerance, which
increase further up to an FIO2 of about 50%, even in
patients who are not hypoxaemic.17 These changes
likely result from a slower breathing pattern, which
allows a greater length of time for exhalation,
hence allowing reduced lung hyperinflation.17 The
benefits of increasing the FIO2 could potentially be
produced through three mechanisms—decreased
carotid body stimulation, increased arterial oxygen
content and increased pulmonary vasodilation.
Recent data suggest that decreased carotid body
stimulation may be an important target for inter-
vention.18 Other strategies such as the use of
portable oxygen concentrators,19 pharmacothera-
pies to stimulate haematopoiesis20 and pharma-cotherapies to induce pulmonary vasodilation21
could be applied.
Bronchodilators
Both anticholinergics and b-agonists are modestly
effective in improving exercise tolerance. This
effect is enhanced when long-acting agents are
taken regularly.22,23 Bronchodilators also reduce
the dynamic hyperinflation that occurs with faster
respiratory rates. It remains to be seen whether
combination therapy incorporating both types of
long-acting agents is more effective than mono-
therapy in improving exercise tolerance in the long-
term.
Surgery
Lung-volume-reduction surgery has been shown to
improve exercise tolerance by improving lung
mechanics and reducing hyperinflation.24 Although
lung transplantation normalises lung function and
improves exercise tolerance, the latter is not
normalised.25 This observation highlights the im-
portance of non-pulmonary factors in determining
exercise tolerance in COPD. Pulmonary rehabilita-
tion is indicated before and after surgical inter-
vention.The benefits of exercise training in
pulmonary rehabilitation for diseases
other than COPD
Asthma
Physical training is beneficial in patients with
asthma26 and, as in patients affected by COPD,
there is a negative correlation between exercise
capacity and disease severity. A study conducted by
Cochrane and Clark26 to determine the effects of a
3-month physical training programme, showed
significant (P40:05) improvements in cardiore-
spiratory performance and reduced breathlessness
in asthma subjects who underwent training
(n ¼ 18), compared with those who did not
(n ¼ 18). An important finding from this study was
that continuous medical supervision of training was
required to monitor the subject’s asthma and to
adjust treatment accordingly.26
Cystic fibrosis
The benefits of pulmonary rehabilitation are also
evident in patients with cystic fibrosis. In a study
published by Braggion et al. in 1989,27 children with
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Figure 5 The relationship between survival and fitness
(as measured by peak oxygen uptake [VO2peak]) in
patients with cystic fibrosis. High fitness defined as
VO2peakX85% of predicted; intermediate, VO2peak
59–81% of predicted; low, VO2peakp58% of predicted.28
J. Reardon et al.S24cystic fibrosis and mild airway obstruction (n ¼ 10)
were shown to have significantly (Po0:05) in-
creased endurance following an 8-week aerobic
training programme. These data are important,
because previous studies have shown that aerobic
fitness is a strong predictor of survival in patients
with cystic fibrosis.28 Indeed, 8-year survival is 28%
in patients with a peak oxygen uptake (VO2-
peak)p58% of predicted, compared with 83% survival in patients
with a VO2peakX82% of predicted (Fig. 5).
28Other forms of chronic respiratory disease
In an analysis of patients admitted to a 4-week in-
patient comprehensive pulmonary rehabilitation
programme, Foster et al.29 showed that the
benefits of pulmonary rehabilitation are compar-
able between COPD patients and those with other
forms of chronic respiratory disease. In fact,
patients with a range of different chronic respira-
tory illnesses (e.g. pulmonary fibrosis and neuro-
muscular disease) all showed improvements in
ambulatory measurements following pulmonary
rehabilitation. These findings are supported by
those of Congleton et al.30 who examined the
outcome from a 6-week outpatient pulmonary
rehabilitation programme in patients with COPD
(n ¼ 15), interstitial pulmonary fibrosis (n ¼ 6) and
chest wall disease (n ¼ 8). All the patients showed
an improvement in physical functioning and also inHRQoL, as measured using the Short Form-36
measure.31
There is certainly an emerging interest in, and
evidence supporting the use of, pulmonary rehabi-
litation in many patients with chronic respiratory
diseases who would not have formerly been
considered to be suitable candidates for rehabilita-
tion.32The role of patient self-management
education
Principles of patient education
As we have already stated, patient education is an
important, if not essential, component for the care
of patients with COPD.33 Traditionally, patient
education has focused on providing the patient
with disease-specific information and appropriate
technical skills.5 In contrast to traditional educa-
tion, patient self-management education teaches
problem-solving skills designed to help patients
identify problems associated with their disease,
and overcome them by designing ‘action plans’ in
partnership with their health care provider.5 The
objective of self-management education, there-
fore, is to improve the patient’s self-efficacy, and
confidence in their ability to make life-improving
changes, with the ultimate aim of achieving a
better clinical outcome.
Several strategies could conceivably be used to
improve patient self-efficacy. These include ad-
dressing any deficits in skills that are required by
the patient, encouraging the patient to enlist the
support of others in practising new skills, and
providing positive and constructive feedback on the
patient’s experiences. In addition, sharing the
successes of others with the patient, reviewing
progress regularly, and discussing the means to
cope with potential threats to therapeutic adher-
ence, are all potential means of improving self-
efficacy.
Defining the benefits of self-management
education
The most recent evidence for the benefits of self-
management education comes from two rando-
mised clinical trials, published by Monninkhof et al.
and Bourbeau et al. both in 2003.34,35 These were
well-designed prospective trials comparing patients
receiving usual care with patients enlisted to
comprehensive skill-orientated self-management
programmes. At 1 year of follow-up, the trial
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Figure 6 Kaplan–Meier curves showing the probability of
not being admitted to hospital during 12 months follow-
up of patients with COPD treated with self-management
education or usual care for a 2-month period.35
Pulmonary rehabilitation for COPD S25reported by Bourbeau et al.35 showed that, among
patients undergoing self-management education
(n ¼ 95), there were overall reductions in the
number of unscheduled hospital visits (Fig. 6),
including reduced admissions for exacerbations
(39.8%; P ¼ 0:01) and reduced admissions for other
health problems (57.1%; P ¼ 0:01). Furthermore,
self-management education was associated with
fewer emergency department (41.0%; P ¼ 0:02)
and unscheduled physician visits (58.9%;
P ¼ 0:03). Health status, as measured by the St.
George Respiratory Questionnaire (SGRQ),36 was
improved with self-management education, but
only at 4 months. In contrast, the results of
Monninkhof et al. failed to show positive effect-
s—patient-reported exacerbations actually in-
creased with self-management education, and
there was no improvement in QoL (SGRQ). Mon-
ninkhof et al. concluded that self-management
education is not an efficient or cost-effective
treatment modality. This conclusion, in addition
to contradicting the findings of Bourbeau et al., is
also contrary to another 1-year randomised trial
conducted in Norway. In the Norwegian trial, self-
management education improved outcomes and
reduced costs in patients with COPD—for every
Norwegian Krone (NOK) spent on education, there
was a saving of 4.8 NOK.37
The reasons for these apparent discrepancies
could be due to the fact that, in the Monninkhof
trial, the patients were stabilised at baseline,
having already completed a 4-month inhaled
corticosteroid substudy. Also, these patients were
highly motivated (having agreed to participate in
the two trials over 3 years) but compared with the
patients in the Bourbeau trial were younger, less
well-educated, had less severe functional impair-
ment, had fewer exacerbations in the year preced-ing the trial and had better SGRQ scores at
baseline. Prompted by these conflicting results,
and anecdotal reports of patient satisfaction in the
self-management arm, a qualitative follow-up was
conducted in a subgroup of 20 patients who
participated in the Monninkhof trial.38 During
interviews, these 20 patients expressed very
favourable experiences regarding self-manage-
ment, including increased energy levels, emotional
well-being, self-confidence, coping skills and
autonomy. Taken together, these results suggest
that the SGRQ and other such measures may not
sufficiently capture the benefits associated with
self-management education programmes, in pa-
tients with COPD.
Unanswered questions
While there are positive data regarding the useful-
ness of patient self-management education, ques-
tions remain as to precisely how much patient
benefit is afforded by this strategy, how to identify
which patients will benefit the most and whether or
not the economic costs justify the clinical benefits.
In addition, it will be important to determine which
aspects of self-management are critical for cost-
effective success, and which self-management
strategies result in long-term maintenance of
positive behaviour. These considerations accepted,
providing patients with the tools they need to
properly manage a chronic condition such as COPD,
should be seen as an important part of pulmonary
rehabilitation.33Conclusions
A great deal of research has been carried out in
order to define the best application of pulmonary
rehabilitation. While recent research has yielded
some useful insights into the potential benefits
associated with the use of rehabilitation in patients
with chronic respiratory disease, more work is
required to fully define the best use of the core
components: exercise training and patient self-
management training. By refining the training
methods used, patients will be able to exercise at
greater intensities than might be expected, and
thereby gain greater benefit from their training.
Establishing the optimum duration of the exercise
programme will be an important research objective
in the future.
Patient self-management education holds much
promise for increasing the ability of patients to
come to terms with their disease and cope with the
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there is some evidence to suggest that this
modality cannot only improve the well-being of
patients, but can also reduce health care expendi-
ture. Once again, further research will be required
to establish definitively how beneficial self-man-
agement is for the patient with COPD, which
patients will benefit most, and the impact of cost
implications.
Recent data have underlined the importance of
pulmonary rehabilitation in the management of
COPD, and firmly place this concept at the centre
of efforts to manage patients throughout the
course of their disease.References
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